MiR-377-3p inhibited CPT1C expression by targeting its 3′-UTR and suppressed fatty acid β-oxidation, leading to repression of HCC proliferation, migration, invasion, and metastasis in vitro and in vivo. This evidence concerns the gene CPT1C and hepatocellular carcinoma.